Independent Investors Inc Pfizer Inc Transaction History

Independent Investors Inc

$453 Million
Q2 2024

A detailed history of Independent Investors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Independent Investors Inc holds 13,290 shares of PFE stock, worth $394,181. This represents 0.08% of its overall portfolio holdings.

Number of Shares

13,290

Previous 13,290 -0.0%

Holding current value

$394,181

Previous $368,000 0.82%

% of portfolio

0.08%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $15,171 - $17,421	-586 Reduced 4.22%	13,290 $368,000
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $2,613 - $3,394	-100 Reduced 0.72%	13,876 $399,000
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $26,698 - $31,208	-832 Reduced 5.62%	13,976 $463,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $41,750 - $54,500	-1,000 Reduced 6.33%	14,808 $759,000
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $31 - $37	-1 Reduced 0.01%	15,808 $580,000
Q2 2020 Jul 09, 2020	SELL	$30.12 - $36.54 $240,960 - $292,320	-8,000 Reduced 33.6%	15,809 $516,000
Q4 2019 Jan 15, 2020	SELL	$32.92 - $37.36 $40,294 - $45,728	-1,224 Reduced 4.89%	23,809 $932,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $74,856 - $97,067	-2,304 Reduced 8.43%	25,033 $899,000
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $25,885 - $29,064	-700 Reduced 2.5%	27,337 $1.18 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $37,917 - $45,991	-1,100 Reduced 3.78%	28,037 $1.24 Million
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $37,816 - $40,124	1,137 Added 4.06%	29,137 $1.06 Million
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $868,000 - $956,200	28,000	28,000 $999,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Independent Investors Inc with notifications on news.

Account

Independent Investors Inc Pfizer Inc Transaction History